Skip to main content

and
  1. Article

    Open Access

    Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy

    Photodynamic therapy (PDT) in early squamous cell carcinoma of the bronchus has been shown to result in complete response (CR) and cure. However, local recurrence after PDT develops frequently even after compl...

    T Kawaguchi, S Yamamoto, N Naka, K Okishio, S Atagi, M Ogawara in British Journal of Cancer (2000)

  2. No Access

    Article

    Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation

    Patients with small-cell lung cancer who survive more than 2 years have a significantly increased risk (relative risk of 3.6) of develo** a second primary tumour. The cessation of cigarette smoking after suc...

    M Kawahara, S Ushijima, T Kamimori, N Kodama, M Ogawara in British Journal of Cancer (1998)

  3. No Access

    Article

    Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer

    A phase II trial was conducted to evaluate the efficacy and toxicity of the Egorin's carboplatin dosing formula with 14-day oral etoposide in 38 elderly patients with small-cell lung cancer (SCLC). The overall...

    K Matsui, N Masuda, M Fukuoka, T Yana, T Hirashima, T Komiya in British Journal of Cancer (1998)

  4. No Access

    Article

    A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis

    We have evaluated the feasibility, toxicity, and tumour response of concurrent whole-brain radiotherapy (WBRT) and chemotherapy with cisplatin, vindesine and mitomycin in the treatment of 33 patients with brai...

    K Furuse, T Kamimori, M Kawahara, N Kodama, M Ogawara, S Atagi in British Journal of Cancer (1997)

  5. No Access

    Article

    CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer

    Sixty-three patients with extensive-stage small-cell lung cancer were randomized to receive either cyclophosphamide, vincristine, doxorubicin and etoposide (CODE) alone or CODE plus recombinant human granulocy...

    M Fukuoka, N Masuda, S Negoro, K Matsui, T Yana, S Kudoh in British Journal of Cancer (1997)